A dual-color fluorescence-based platform to identify selective inhibitors of Akt signaling.
BACKGROUND: Inhibition of Akt signaling is considered one of the most promising therapeutic strategies for many cancers. However, rational target-orientated approaches to cell based drug screens for anti-cancer agents have historically been compromised by the notorious absence of suitable control ce...
Main Authors: | Aranzazú Rosado, Fabian Zanella, Beatriz Garcia, Amancio Carnero, Wolfgang Link |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2267216?pdf=render |
Similar Items
-
Using multiplexed regulation of luciferase activity and GFP translocation to screen for FOXO modulators
by: Carnero Amancio, et al.
Published: (2009-02-01) -
The method for integrating dual-color fluorescence colocalization and single molecule photobleaching technology on the theophylline sensing platform
by: Dong Zhang, et al.
Published: (2020-01-01) -
Azasteroid Alkylators as Dual Inhibitors of AKT and ERK Signaling for the Treatment of Ovarian Carcinoma
by: Panagiotis Dalezis, et al.
Published: (2020-05-01) -
Simultaneous Dual-Color Fluorescence Microscope: A Characterization Study
by: Zheng Li, et al.
Published: (2013-01-01) -
Development of Dual-Pathway Inhibitors of Raf/MEK/ERK and PI3K/Akt Signaling Pathways.
by: Fraser, Sasha
Published: (2011)